KOROSTATIN Drug Patent Profile
✉ Email this page to a colleague
When do Korostatin patents expire, and when can generic versions of Korostatin launch?
Korostatin is a drug marketed by Holland Rantos and is included in one NDA.
The generic ingredient in KOROSTATIN is nystatin. There is one drug master file entry for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the nystatin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Korostatin
A generic version of KOROSTATIN was approved as nystatin by FOUGERA PHARMS on September 23rd, 1982.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for KOROSTATIN?
- What are the global sales for KOROSTATIN?
- What is Average Wholesale Price for KOROSTATIN?
Summary for KOROSTATIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 13 |
| DailyMed Link: | KOROSTATIN at DailyMed |
US Patents and Regulatory Information for KOROSTATIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Holland Rantos | KOROSTATIN | nystatin | TABLET;VAGINAL | 061718-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
